バイオテクノロジー原料市場：供給源別、用途別-2025-2030年の世界予測

バイオテクノロジー原料市場の2023年の市場規模は460億3,000万米ドルで、2024年には489億3,000万米ドルに達すると予測され、CAGR 6.79％で成長し、2030年には729億3,000万米ドルに達すると予測されています。

バイオテクノロジー原料市場には、主に医薬品、化粧品、飲食品など、さまざまな産業で使用される生物学的に生産された化合物の範囲が含まれます。これらの成分は、発酵、遺伝子工学、細胞培養などのバイオテクノロジー的手法によって生産されます。バイオテクノロジー原料の必要性は、天然で持続可能な製品、高度な機能性、精密な製造に対する需要の高まりから生じています。その用途は主に、医薬品の製剤化、生物活性成分を含むスキンケアソリューションの化粧品、高級添加物や健康増進成分の食品産業など多岐にわたる。最終用途の範囲では医薬品が圧倒的だが、化粧品は製品の効能を高めるためにバイオテクノロジー・ソリューションを急速に取り入れています。この市場に影響を与える主な成長要因には、天然有機製品への志向の高まり、バイオプロセスにおける技術進歩、バイオテクノロジー研究への多額の投資などがあります。市場はまた、持続可能なバイオ製品に対する規制上の支援からも恩恵を受けています。自然な健康効果に対する消費者の意識の拡大や、合成生物学のイノベーションを活用した新規成分の創出にもビジネスチャンスがあります。企業は、研究における資源共有のための潜在的な共同研究を活用することができます。しかし、市場成長は、高い生産コスト、厳しい規制基準、専門知識を必要とする複雑な生産工程などの課題に直面しています。さらに、スケーラビリティの問題や知的財産権に関する懸念も大きなハードルとなり得る。技術革新と研究の機会には、コスト効率の高い発酵技術の開発、生合成用の新規微生物の探索、バイオテクノロジー原料の安定性と効力の強化などが含まれます。市場の競争は激しいが、技術革新と持続可能な製品に対する消費者の嗜好に後押しされ、その性質は有望です。企業は、生産方法を最適化し、コストを削減し、進化する世界スタンダードへの適合を確実にするために、研究開発に投資することをお勧めします。研究機関や学術団体との戦略的パートナーシップの構築は、こうした課題への対応に役立ち、最先端技術へのアクセスを容易にし、製品開発サイクルを短縮することができると思われます。

市場力学：急速に進化するバイオテクノロジー原料市場の主要市場インサイトを公開

バイオテクノロジー原料市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオテクノロジー原料の健康効果に関する消費者意識の高まり
  • バイオテクノロジー産業に対する政府のイニシアチブの高まり
• 市場抑制要因
  • 原料の入手可能性の制限と不安定な価格
• 市場機会
  • バイオテクノロジー分野における継続的な研究開発活動
  • 化粧品・パーソナルケア業界からのバイオテクノロジー原料需要の増加
• 市場の課題
  • バイオテクノロジー原料に関連する製造の複雑さ

ポーターの5つの力：バイオテクノロジー原料市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、バイオテクノロジー原料市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオテクノロジー原料市場における外部からの影響の把握

外部マクロ環境要因は、バイオテクノロジー原料市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオテクノロジー原料市場における競合情勢の把握

バイオテクノロジー原料市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオテクノロジー原料市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオテクノロジー原料市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオテクノロジー原料市場における成功への道筋を描く

バイオテクノロジー原料市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオテクノロジー原料の健康上の利点に関する消費者の意識を高める
    • バイオテクノロジー産業に対する政府の取り組みの高まり
  • 抑制要因
    • 原材料の供給不足と価格の変動
  • 機会
    • バイオテクノロジー分野における継続的な研究開発活動
    • 化粧品・パーソナルケア業界からのバイオテクノロジー原料需要の増加
  • 課題
    • バイオテクノロジー原料に関連する製造の複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオテクノロジー原料市場：ソース別

• 細菌
• 菌類
• 酵母

第7章 バイオテクノロジー原料市場：用途別

• 化粧品
• フレグランス
• パーソナルケア

第8章 南北アメリカのバイオテクノロジー原料市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイオテクノロジー原料市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオテクノロジー原料市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Advanced Biotech
• Amyris, Inc.
• AstraZeneca PLC
• Becton Dickinson and Company
• bioMerieux SA
• Bloomage Biotechnology Corp., Ltd.
• Boehringer Ingelheim International GmbH
• Contipro a.s.
• Eli Lilly and Company
• Evolva Holding SA
• Evonik Industries AG
• Firmenich SA by Koninklijke DSM N.V.
• Givaudan SA
• Hayashibara Co., Ltd. by NAGASE & CO., LTD.
• International Flavors & Fragrances Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Sollice Biotech
• Symrise AG
• T. HASEGAWA CO., LTD.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. BIOTECH INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 2. BIOTECH INGREDIENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOTECH INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOTECH INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOTECH INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOTECH INGREDIENTS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FRAGRANCES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. BIOTECH INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. BIOTECH INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Biotech Ingredients Market was valued at USD 46.03 billion in 2023, expected to reach USD 48.93 billion in 2024, and is projected to grow at a CAGR of 6.79%, to USD 72.93 billion by 2030.

The biotech ingredients market encompasses a range of biologically-produced compounds used in various industries, primarily within pharmaceuticals, cosmetics, and food and beverages. These ingredients are produced through biotechnological methods, such as fermentation, genetic engineering, and cell culture. The necessity for biotech ingredients arises from the growing demand for natural and sustainable products, advanced functionality, and precision manufacturing. Their applications primarily span pharmaceuticals for drug formulation, cosmetics for skincare solutions with bioactive elements, and the food industry for premium additives and health-enhancing components. In terms of end-use scope, pharmaceuticals dominate, though cosmetics are rapidly integrating biotech solutions for enhanced product efficacy. Key growth factors influencing this market include an increasing inclination towards natural and organic products, technological advancements in bioprocesses, and significant investment in biotech research. The market also benefits from regulatory support for sustainable bio-products. Opportunities lie in expanding consumer awareness about natural health benefits and leveraging innovations in synthetic biology to create novel ingredients. Companies may capitalize on potential collaborations for resource sharing in research. However, market growth faces challenges such as high production costs, stringent regulatory standards, and complex production processes that demand specialized knowledge. Additionally, scalability issues and intellectual property concerns can pose significant hurdles. Innovation and research opportunities include developing cost-effective fermentation technologies, exploring novel microorganisms for biosynthesis, and enhancing the stability and efficacy of biotech ingredients. The market's nature is competitive yet promising, driven by technological innovation and consumer preferences for sustainable products. Companies are advised to invest in R&D to optimize production methods, reduce costs, and ensure compliance with evolving global standards. Identifying strategic partnerships with research institutions and academic bodies could aid in addressing these challenges, facilitating access to cutting-edge technology and shortening product development cycles.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotech Ingredients Market

The Biotech Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing consumer awareness about health benefits of biotech ingredients
  • Rising government initiatives for biotechnology industry
• Market Restraints
  • Limited availability & volatile prices of raw materials
• Market Opportunities
  • Ongoing research and development activities in the field of biotechnology
  • Increasing biotech ingredients demand from the cosmetic & personal care industry
• Market Challenges
  • Manufacturing complexities associated with the biotech ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Biotech Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotech Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotech Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotech Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotech Ingredients Market

A detailed market share analysis in the Biotech Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotech Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotech Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotech Ingredients Market

A strategic analysis of the Biotech Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotech Ingredients Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Biotech, Amyris, Inc., AstraZeneca PLC, Becton Dickinson and Company, bioMerieux SA, Bloomage Biotechnology Corp., Ltd., Boehringer Ingelheim International GmbH, Contipro a.s., Eli Lilly and Company, Evolva Holding SA, Evonik Industries AG, Firmenich SA by Koninklijke DSM N.V., Givaudan SA, Hayashibara Co., Ltd. by NAGASE & CO., LTD., International Flavors & Fragrances Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sollice Biotech, Symrise AG, T. HASEGAWA CO., LTD., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Biotech Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Source, market is studied across Bacteria, Fungi, and Yeast.
• Based on Application, market is studied across Cosmetics, Fragrances, and Personal Care.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumer awareness about health benefits of biotech ingredients
    • 5.1.1.2. Rising government initiatives for biotechnology industry
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability & volatile prices of raw materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities in the field of biotechnology
    • 5.1.3.2. Increasing biotech ingredients demand from the cosmetic & personal care industry
  • 5.1.4. Challenges
    • 5.1.4.1. Manufacturing complexities associated with the biotech ingredients
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biotech Ingredients Market, by Source

• 6.1. Introduction
• 6.2. Bacteria
• 6.3. Fungi
• 6.4. Yeast

7. Biotech Ingredients Market, by Application

• 7.1. Introduction
• 7.2. Cosmetics
• 7.3. Fragrances
• 7.4. Personal Care

8. Americas Biotech Ingredients Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotech Ingredients Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotech Ingredients Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Advanced Biotech
• 3. Amyris, Inc.
• 4. AstraZeneca PLC
• 5. Becton Dickinson and Company
• 6. bioMerieux SA
• 7. Bloomage Biotechnology Corp., Ltd.
• 8. Boehringer Ingelheim International GmbH
• 9. Contipro a.s.
• 10. Eli Lilly and Company
• 11. Evolva Holding SA
• 12. Evonik Industries AG
• 13. Firmenich SA by Koninklijke DSM N.V.
• 14. Givaudan SA
• 15. Hayashibara Co., Ltd. by NAGASE & CO., LTD.
• 16. International Flavors & Fragrances Inc.
• 17. Merck & Co., Inc.
• 18. Novartis AG
• 19. Pfizer Inc.
• 20. Sanofi S.A.
• 21. Sollice Biotech
• 22. Symrise AG
• 23. T. HASEGAWA CO., LTD.
• 24. Teva Pharmaceutical Industries Ltd.
• 25. Viatris Inc.